{"id":"placebo-of-nicotine-transdermal-patch","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert formulations designed to match the appearance and delivery method of the active drug but contain no pharmacologically active ingredient. In this case, it mimics a nicotine transdermal patch but delivers no nicotine, allowing researchers to isolate the therapeutic effect of nicotine from placebo response and natural disease progression in phase 3 trials.","oneSentence":"This is a placebo control formulation containing no active nicotine, used as a comparator in clinical trials to assess the true efficacy of nicotine transdermal patches.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:21.044Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control for nicotine replacement therapy trials in smoking cessation"}]},"trialDetails":[{"nctId":"NCT05610800","phase":"PHASE2","title":"Exenatide for Smoking Cessation and Prevention of Weight Gain","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-12-07","conditions":"Smoking Cessation, Weight Gain","enrollment":140},{"nctId":"NCT06173778","phase":"PHASE2","title":"Semaglutide for Post-Smoking Cessation Weight Management","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2024-04-23","conditions":"Obesity, Overweight, Cigarette Smoking","enrollment":197},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT02271919","phase":"PHASE4","title":"Varenicline and Combined NRT for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-05-14","conditions":"Cigarette Smoker, Tobacco Use Disorder","enrollment":631},{"nctId":"NCT05746273","phase":"PHASE2","title":"Depressed Mood Improvement Through Nicotine Dosing 3","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-04-15","conditions":"Depressive Disorder","enrollment":60},{"nctId":"NCT07250230","phase":"NA","title":"Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Undergoing Thoracic Surgery: A Randomized Controlled Pilot Study","status":"RECRUITING","sponsor":"Henan Provincial People's Hospital","startDate":"2025-11-30","conditions":"Nicotine Dependence, Thoracic Diseases, Analgesia","enrollment":80},{"nctId":"NCT02720445","phase":"PHASE2","title":"Memory Improvement Through Nicotine Dosing (MIND) Study","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2017-01-13","conditions":"Mild Cognitive Impairment","enrollment":348},{"nctId":"NCT06066996","phase":"EARLY_PHASE1","title":"Evaluation of the Electronic Cigarette Withdrawal Syndrome","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-11-28","conditions":"E-cigarette Use, Withdrawal","enrollment":150},{"nctId":"NCT05587361","phase":"PHASE4","title":"Beta-Adrenergic Modulation of Drug Cue Reactivity","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2024-11-26","conditions":"Tobacco Use Disorder, Nicotine Dependence, Cigarette Smoking","enrollment":80},{"nctId":"NCT05136690","phase":"PHASE1","title":"Evoked Responses as Pharmacodynamic Biomarkers in Healthy and Schizophrenic Participants (MK-4334-007)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2022-04-27","conditions":"Cognitive Impairment Associated With Schizophrenia","enrollment":38},{"nctId":"NCT03281694","phase":"PHASE1","title":"The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2018-05","conditions":"Cognitive Change","enrollment":""},{"nctId":"NCT01511614","phase":"NA","title":"Nicotine Withdrawal Symptoms and Smoking Relapse","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2013-05-20","conditions":"Nicotine Dependence","enrollment":112},{"nctId":"NCT01329614","phase":"EARLY_PHASE1","title":"Effects of Nicotine Replacement and Repeated Cue Exposure on Cigarette Craving","status":"COMPLETED","sponsor":"Columbia University","startDate":"2009-10","conditions":"Tobacco Use Disorder","enrollment":40},{"nctId":"NCT03000387","phase":"PHASE4","title":"Personalized Dosing of Nicotine Replacement (NRT to Effect)","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2018-01-23","conditions":"Tobacco Use Disorder, Nicotine Dependence","enrollment":211},{"nctId":"NCT04286295","phase":"NA","title":"Cytisine Compared to Combination NRT in Relapsed Smokers","status":"TERMINATED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2022-03-14","conditions":"Smoking Cessation, Coronary Artery Disease","enrollment":13},{"nctId":"NCT04084210","phase":"PHASE2","title":"Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-09-09","conditions":"Nicotine Dependence","enrollment":209},{"nctId":"NCT03408574","phase":"PHASE1","title":"The Nicotinic Cholinergic System and Cognitive Aging","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2016-10-01","conditions":"Healthy Aging","enrollment":104},{"nctId":"NCT03492463","phase":"PHASE2","title":"The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products","status":"COMPLETED","sponsor":"Duke University","startDate":"2018-08-06","conditions":"Nicotine Dependence, Cigarettes","enrollment":94},{"nctId":"NCT03838484","phase":"NA","title":"Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2019-05-10","conditions":"Schizophrenia, Impulsive Behavior","enrollment":18},{"nctId":"NCT05301660","phase":"EARLY_PHASE1","title":"Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia","status":"UNKNOWN","sponsor":"Sir Run Run Shaw Hospital","startDate":"2022-03-22","conditions":"Schizophrenia","enrollment":80},{"nctId":"NCT04608201","phase":"PHASE3","title":"Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-12-09","conditions":"SARS-COV2","enrollment":32},{"nctId":"NCT00790829","phase":"NA","title":"Preemptive Use of the Nicotine Patch for Postoperative Pain Relief After Open Abdominal Surgery","status":"TERMINATED","sponsor":"Stony Brook University","startDate":"2007-08","conditions":"Postoperative Pain","enrollment":30},{"nctId":"NCT00440830","phase":"PHASE4","title":"Nicotine Patch as an Analgesic Adjuvant After Surgery","status":"COMPLETED","sponsor":"Columbia University","startDate":"2005-12","conditions":"Pain","enrollment":68},{"nctId":"NCT02859142","phase":"PHASE4","title":"Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2018-03-29","conditions":"Smoking Cessation, Alcohol Drinking","enrollment":122},{"nctId":"NCT02501265","phase":"PHASE2","title":"Adaptive Pharmacotherapy for Smoking Cessation","status":"COMPLETED","sponsor":"Duke University","startDate":"2017-06-06","conditions":"Nicotine Dependence","enrollment":188},{"nctId":"NCT00064844","phase":"PHASE4","title":"Combination Nicotine Replacement for Alcoholic Smokers","status":"COMPLETED","sponsor":"Yale University","startDate":"2002-08","conditions":"Smoking, Alcoholism","enrollment":96},{"nctId":"NCT02905734","phase":"PHASE4","title":"Nicotine Replacement Therapy in Nicotine-dependent Arrestees","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-01-03","conditions":"Nicotine Dependence","enrollment":800},{"nctId":"NCT04598594","phase":"PHASE3","title":"Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-11-06","conditions":"Covid19, SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere","enrollment":220},{"nctId":"NCT01944423","phase":"EARLY_PHASE1","title":"Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine","status":"COMPLETED","sponsor":"University of Texas at Austin","startDate":"2013-10","conditions":"Nicotine Addiction, Panic Attack","enrollment":53},{"nctId":"NCT04583410","phase":"PHASE3","title":"Efficacy of Nicotine in Preventing COVID-19 Infection","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-10-22","conditions":"Covid19, SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere","enrollment":1633},{"nctId":"NCT04035603","phase":"PHASE2","title":"Multimodal Cue Exposure Therapy for Smoking Cessation","status":"WITHDRAWN","sponsor":"Boston University Charles River Campus","startDate":"2020-10-01","conditions":"Smoking Cessation","enrollment":""},{"nctId":"NCT03847155","phase":"NA","title":"Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery","status":"COMPLETED","sponsor":"University Hospital Ostrava","startDate":"2015-09-23","conditions":"Nicotine Dependence","enrollment":52},{"nctId":"NCT02975297","phase":"PHASE1, PHASE2","title":"Exenatide Once Weekly for Smoking Cessation","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2016-07","conditions":"Smoking Cessation","enrollment":84},{"nctId":"NCT01213524","phase":"PHASE2","title":"Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia","status":"COMPLETED","sponsor":"Brown University","startDate":"2005-09","conditions":"Tobacco Use Disorder, Schizophrenia","enrollment":75},{"nctId":"NCT01907594","phase":"PHASE2","title":"Effects of Nicotine Replacement Therapy and D-cycloserine on Nicotine Treatment Seekers","status":"WITHDRAWN","sponsor":"New York State Psychiatric Institute","startDate":"2013-08","conditions":"Cigarette Smoking","enrollment":""},{"nctId":"NCT02747628","phase":"PHASE4","title":"Transdermal Nicotine and Melatonin Patches for Postoperative Pain Relief","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2013-04","conditions":"Postoperative Pain Relief","enrollment":60},{"nctId":"NCT00851357","phase":"PHASE3","title":"Telephone Counseling and the Distribution of Nicotine Patches to Smokers","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2009-02","conditions":"Smoking Cessation","enrollment":4200},{"nctId":"NCT02312934","phase":"PHASE2","title":"Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2015-08","conditions":"Chemo Brain, Chemotherapy-related Cognitive Impairment, Chemo Fog","enrollment":22},{"nctId":"NCT02551692","phase":"NA","title":"Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)","status":"COMPLETED","sponsor":"Duke University","startDate":"2016-01","conditions":"Cigarette Smoking","enrollment":125},{"nctId":"NCT02420327","phase":"NA","title":"Low-Dose Galantamine to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2014-09","conditions":"Basic Science Study of the Mechanisms of Attentional Enhancement by Compounds Acting on the Nicotinic Receptor","enrollment":43},{"nctId":"NCT03416569","phase":"NA","title":"Effects of Prazosin on the Attention-Enhancing Effects of Nicotine","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2018-03","conditions":"no Condition, Basic Science","enrollment":""},{"nctId":"NCT01223404","phase":"NA","title":"Nicotinic Modulation of the Default Network","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2010-10","conditions":"Magnetic Resonance Imaging, Cognition, Nicotine","enrollment":21},{"nctId":"NCT00086411","phase":"PHASE2","title":"Comparing Smoking Treatment Programs for Lighter Smokers - 1","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2003-09","conditions":"Tobacco Use Disorder","enrollment":260},{"nctId":"NCT02685072","phase":"PHASE4","title":"Progesterone Augmentation of Nicotine Replacement Therapy Study","status":"COMPLETED","sponsor":"Yale University","startDate":"2016-04-07","conditions":"Smoking Cessation","enrollment":64},{"nctId":"NCT03262233","phase":"PHASE4","title":"Stress Neuroadaptation in Tobacco Dependence","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2015-04-01","conditions":"Nicotine Dependence","enrollment":226},{"nctId":"NCT00578669","phase":"PHASE3","title":"Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms","status":"COMPLETED","sponsor":"Butler Hospital","startDate":"2008-04","conditions":"Major Depressive Disorder, Nicotine Dependence, Depression","enrollment":206},{"nctId":"NCT02487953","phase":"PHASE2","title":"Electronic Nicotine Delivery Systems as a Smoking Cessation Treatment","status":"WITHDRAWN","sponsor":"Duke University","startDate":"2018-07","conditions":"Nicotine Dependence","enrollment":""},{"nctId":"NCT00756275","phase":"NA","title":"Varenicline and Motivational Advice for Smokers With Substance Use Disorders","status":"COMPLETED","sponsor":"Brown University","startDate":"2009-01","conditions":"Smoking Cessation, Nicotine Dependence","enrollment":158},{"nctId":"NCT00440505","phase":"PHASE4","title":"Effect of Nicotine on Chronic Pelvic Pain","status":"COMPLETED","sponsor":"Columbia University","startDate":"2004-02","conditions":"Pelvic Pain","enrollment":20},{"nctId":"NCT00790569","phase":"NA","title":"Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking","status":"COMPLETED","sponsor":"Butler Hospital","startDate":"2008-09","conditions":"Bladder Cancer, Cervical Cancer, Esophageal Cancer","enrollment":315},{"nctId":"NCT00664755","phase":"PHASE2","title":"Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2007-07","conditions":"Nicotine Dependence","enrollment":140},{"nctId":"NCT00364156","phase":"PHASE3","title":"Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2004-06","conditions":"TOBACCO USE CESSATION","enrollment":568},{"nctId":"NCT01406223","phase":"PHASE3","title":"Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation","status":"COMPLETED","sponsor":"Duke University","startDate":"2011-07","conditions":"Nicotine Dependence","enrollment":282},{"nctId":"NCT01474265","phase":"PHASE4","title":"Sympathovagal Balance in Smoking Cessation","status":"COMPLETED","sponsor":"Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH","startDate":"2011-11","conditions":"Smoking Cessation","enrollment":85},{"nctId":"NCT00755716","phase":"PHASE3","title":"Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study","status":"COMPLETED","sponsor":"UConn Health","startDate":"2006-04","conditions":"Tobacco Dependence","enrollment":57},{"nctId":"NCT01531049","phase":"PHASE2, PHASE3","title":"Smoking Habits and Smoking Cessation in Young Adults","status":"COMPLETED","sponsor":"Tuula Toljamo","startDate":"2012-05","conditions":"Smoking Cessation, Smoking, Habits","enrollment":300},{"nctId":"NCT00258479","phase":"PHASE1","title":"Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents","status":"COMPLETED","sponsor":"Catherine Martin, MD","startDate":"2003-06","conditions":"Tobacco Use Disorder","enrollment":24},{"nctId":"NCT00383747","phase":"PHASE4","title":"The Effects of Nicotine on Cognition in Schizophrenia","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2004-04","conditions":"Schizophrenia","enrollment":60},{"nctId":"NCT02049268","phase":"NA","title":"Neural Mechanisms Underlying Nicotine and Alcohol Combinations","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2013-07","conditions":"Focus: Effects of Nicotine and Alcohol on Brain Circuits","enrollment":12},{"nctId":"NCT01056926","phase":"PHASE1","title":"Neurobiology of Nicotine and Non-nicotine Components of Tobacco Addiction","status":"COMPLETED","sponsor":"Duke University","startDate":"2009-03","conditions":"Smoking","enrollment":147},{"nctId":"NCT00124683","phase":"PHASE2","title":"Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2001-09","conditions":"Tobacco Use Cessation, Tobacco Use Disorder, Schizophrenia","enrollment":59},{"nctId":"NCT00218218","phase":"PHASE2","title":"Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2002-06","conditions":"Schizophrenia and Disorders With Psychotic Features, Tobacco Use Disorder, Schizophrenia","enrollment":48},{"nctId":"NCT01208935","phase":"PHASE2, PHASE3","title":"Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Dependence","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"1999-08","conditions":"Tobacco Dependence","enrollment":157},{"nctId":"NCT00087880","phase":"PHASE2","title":"Maintaining Abstinence in Chronic Cigarette Smokers - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2002-12","conditions":"Tobacco Use Disorder","enrollment":407},{"nctId":"NCT00132821","phase":"PHASE4","title":"Impact of Smoking Cessation on Sleep - 5","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2005-08","conditions":"Tobacco Use Cessation, Sleep Disorders","enrollment":59},{"nctId":"NCT00142831","phase":"PHASE4","title":"Bupropion as an Adjunct to the Nicotine Patch Plus CBT","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"1999-04","conditions":"Tobacco Use Disorder","enrollment":293},{"nctId":"NCT00307203","phase":"PHASE4","title":"Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"1998-08","conditions":"Tobacco-Use Disorder, Schizophrenia, Psychotic Disorders","enrollment":51},{"nctId":"NCT00320697","phase":"PHASE4","title":"Smoking Relapse Prevention in Schizophrenia","status":"COMPLETED","sponsor":"North Suffolk Mental Health Association","startDate":"2006-04","conditions":"Schizophrenia, Schizoaffective Disorder, Smokers","enrollment":25},{"nctId":"NCT01330030","phase":"PHASE2","title":"Selegiline Patch for Treatment of Nicotine Dependence","status":"COMPLETED","sponsor":"Stanford University","startDate":"2005-07","conditions":"Tobacco Use Disorder","enrollment":243},{"nctId":"NCT01456936","phase":"PHASE4","title":"Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-11","conditions":"Smoking Cessation","enrollment":8144},{"nctId":"NCT01314001","phase":"PHASE3","title":"Pharmacogenetics of Nicotine Addiction Treatment","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-12","conditions":"Nicotine Addiction","enrollment":1246},{"nctId":"NCT01783912","phase":"PHASE4","title":"Helping Those With Mental Illness Quit Smoking","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2012-12","conditions":"Smoking, Nicotine Dependence, Mental Disorders","enrollment":270},{"nctId":"NCT00793468","phase":"PHASE2","title":"Relapse Prevention Study in Newly Abstinent Smokers","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2008-12","conditions":"Substance Dependence","enrollment":""},{"nctId":"NCT01560754","phase":"PHASE2","title":"Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease","status":"UNKNOWN","sponsor":"James BOYD MD","startDate":"2012-10","conditions":"Parkinson's Disease","enrollment":160},{"nctId":"NCT01526005","phase":"","title":"Brain Nicotine Receptor Density & Response to Nicotine Patch","status":"COMPLETED","sponsor":"Brentwood Biomedical Research Institute","startDate":"2012-03","conditions":"Cigarette Smoking","enrollment":50},{"nctId":"NCT01314443","phase":"PHASE1, PHASE2","title":"Impact of Smoking Cessation and γ-Tocopherol to Restore Vascular Endothelial Function","status":"COMPLETED","sponsor":"University of Connecticut","startDate":"2011-01","conditions":"Endothelial Dysfunction","enrollment":67},{"nctId":"NCT01315002","phase":"NA","title":"Nicotine Effects on Endophenotypes of Schizophrenia","status":"COMPLETED","sponsor":"University Hospital, Bonn","startDate":"2008-07","conditions":"Schizophrenia","enrollment":121},{"nctId":"NCT01048944","phase":"PHASE4","title":"Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers","status":"COMPLETED","sponsor":"Southern Illinois University Carbondale","startDate":"2005-06","conditions":"Nicotine Dependence","enrollment":197},{"nctId":"NCT00956943","phase":"PHASE2","title":"Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2009-08","conditions":"Nicotine Dependence","enrollment":87},{"nctId":"NCT01443858","phase":"PHASE2","title":"Meclizine as a Potential Smoking Cessation Treatment","status":"COMPLETED","sponsor":"Duke University","startDate":"2011-08","conditions":"Smoking Cessation","enrollment":146},{"nctId":"NCT00308763","phase":"NA","title":"Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2004-01","conditions":"Tobacco Use Disorder","enrollment":594},{"nctId":"NCT00939029","phase":"PHASE2, PHASE3","title":"Highdose Nicotine Patch Therapy for Smokeless Tobacco Use","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2010-07","conditions":"Smokeless Tobacco Use","enrollment":52},{"nctId":"NCT01444131","phase":"PHASE2","title":"Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation","status":"COMPLETED","sponsor":"University of Stellenbosch","startDate":"2011-04","conditions":"Tobacco Dependence","enrollment":446},{"nctId":"NCT01538394","phase":"PHASE4","title":"Clinical Trial to Evaluate the Efficacy of Smoking Cessation","status":"COMPLETED","sponsor":"Josep Maria Ramon Torrell, PhD","startDate":"2012-01","conditions":"Smoking Cessation","enrollment":322},{"nctId":"NCT00390923","phase":"NA","title":"Testing a Full Substitution Therapy Approach As Treatment of Tobacco Dependence","status":"TERMINATED","sponsor":"Centre for Addiction and Mental Health","startDate":"2007-07","conditions":"Nicotine Dependence","enrollment":40},{"nctId":"NCT01216904","phase":"PHASE4","title":"Nicotine Treatment of Impulsivity in Parkinson's Disease","status":"UNKNOWN","sponsor":"University of Vermont","startDate":"2010-10","conditions":"Parkinson's Disease","enrollment":20},{"nctId":"NCT00507975","phase":"PHASE3","title":"Study of Nicotine Patch in Pregnancy (SNIPP)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2007-11","conditions":"Smoking","enrollment":404},{"nctId":"NCT00736710","phase":"NA","title":"rTMS Effects on Smoking Cessation and Cognition in Schizophrenia","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2008-12","conditions":"Cigarette Smoking, Schizophrenia","enrollment":15},{"nctId":"NCT01184664","phase":"PHASE3","title":"Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study)","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2011-04","conditions":"Tobacco Dependence, Smoking Cessation","enrollment":117},{"nctId":"NCT00253747","phase":"PHASE3","title":"Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2005-11","conditions":"ADHD, Smoking","enrollment":255},{"nctId":"NCT00390559","phase":"NA","title":"Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2005-10","conditions":"Drug Addiction, Smoking Cessation","enrollment":80},{"nctId":"NCT00967070","phase":"PHASE1","title":"Skin Sensitization Potential of a New Nicotine Patch","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2005-05","conditions":"Smoking Cessation","enrollment":257},{"nctId":"NCT00967174","phase":"PHASE1","title":"Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2005-05","conditions":"Smoking Cessation","enrollment":42},{"nctId":"NCT00966901","phase":"PHASE1","title":"Photoirritation and Photoallergic Potential of a New Nicotine Patch","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2005-08","conditions":"Smoking Cessation","enrollment":43},{"nctId":"NCT00965913","phase":"PHASE1","title":"Cumulative Skin Irritation Potential of a New 15 mg Nicotine Patch","status":"COMPLETED","sponsor":"McNeil AB","startDate":"2005-05","conditions":"Smoking Cessation","enrollment":42},{"nctId":"NCT01204723","phase":"PHASE1","title":"Medications Development for the Treatment of Cannabis Related Disorders","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2009-08","conditions":"Nicotine Withdrawal, Marijuana Dependence, Cannabis Dependence","enrollment":63},{"nctId":"NCT00332644","phase":"PHASE4","title":"Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2004-09","conditions":"Nicotine Dependence","enrollment":1504},{"nctId":"NCT01104896","phase":"PHASE4","title":"Effect of Daily Nicotine Patch Application on Mechanical Ventilation Weaning in Smoking Patients","status":"UNKNOWN","sponsor":"University of Paris 5 - Rene Descartes","startDate":"2010-01","conditions":"Smoking, Mechanical Ventilation, Intensive Care","enrollment":600},{"nctId":"NCT01085032","phase":"PHASE2","title":"Nicotine Patch Trial in Syrian Primary Care Settings","status":"COMPLETED","sponsor":"University of Memphis","startDate":"2006-08","conditions":"Smoking Cessation","enrollment":269},{"nctId":"NCT00954096","phase":"NA","title":"Nicotine Patch, Blood Flow and Oxidative Stress Study","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2002-10","conditions":"Healthy","enrollment":55}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":18,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of NICOTINE Transdermal patch","genericName":"Placebo of NICOTINE Transdermal patch","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo control formulation containing no active nicotine, used as a comparator in clinical trials to assess the true efficacy of nicotine transdermal patches. Used for Placebo control for nicotine replacement therapy trials in smoking cessation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}